| Interactions between Microbiome and DME (MICBIO)
|
| Bacteria: Actinobacteria |
| Bifidobacterium breve (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bifidobacterium breve co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bifidobacterium ruminatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bifidobacterium ruminatum co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Collinsella intestinalis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Collinsella intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteria: Bacteroidetes |
| Bacteroides caccae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides caccae co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides cellulosilyticus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides cellulosilyticus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides coprophilus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides coprophilus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides dorei co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides dorei co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides dorei co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides eggerthii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides eggerthii co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides fragilis co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides fragilis co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides fragilis co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides intestinalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides sartorii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides sartorii co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides sartorii co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides thetaiotaomicron co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides thetaiotaomicron co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides thetaiotaomicron co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Imatinib mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0858
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides vulgatus co-metabolize the drug Imatinib mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides vulgatus co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides vulgatus co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides vulgatus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides vulgatus co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides xylanisolvens co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides xylanisolvens co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides xylanisolvens co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Odoribacter splanchnicus co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Odoribacter splanchnicus co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Odoribacter splanchnicus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Odoribacter splanchnicus co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Parabacteroides distasonis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Parabacteroides distasonis co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Parabacteroides distasonis co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Parabacteroides johnsonii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Parabacteroides johnsonii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Parabacteroides merdae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Parabacteroides merdae co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Parabacteroides merdae co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Prevotella copri co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteria: Firmicutes |
| Anaerobutyricum hallii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Anaerobutyricum hallii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Anaerococcus hydrogenalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Anaerococcus hydrogenalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Anaerostipes hadrus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Imatinib mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0858
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Anaerostipes hadrus co-metabolize the drug Imatinib mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Anaerotruncus colihominis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Anaerotruncus colihominis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides pectinophilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Bacteroides pectinophilus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Irbesartan |
Click to Show/Hide the Detail |
| Drug ID |
DR0879
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Blautia hansenii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Blautia hansenii co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Blautia hansenii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Butyrivibrio fibrisolvens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Alpha-linolenic acid |
Click to Show/Hide the Detail |
| Drug ID |
DR1988
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Butyrivibrio fibrisolvens co-metabolize the drug Alpha-linolenic acid, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [4], [5] |
| Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Clostridium botulinum co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Clostridium botulinum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clostridium scindens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Clostridium scindens co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clostridium spiroforme (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Clostridium spiroforme co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clostridium symbiosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Clostridium symbiosum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Coprococcus comes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Coprococcus comes co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Dorea formicigenerans (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Dorea formicigenerans co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Enterocloster bolteae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Enterocloster bolteae co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Eubacterium ventriosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Eubacterium ventriosum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Hungatella hathewayi (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Hungatella hathewayi co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Roseburia intestinalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Roseburia intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Ruminococcus gnavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Ruminococcus gnavus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Ruminococcus lactaris (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Ruminococcus lactaris co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteria: Proteobacteria |
| Edwardsiella tarda (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Edwardsiella tarda co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Enterobacter cancerogenus (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Enterobacter cancerogenus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Proteus penneri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Proteus penneri co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Providencia stuartii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Providencia stuartii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Shewanella oneidensis (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Sulfamethoxazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1511
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Shewanella oneidensis co-metabolize the drug Sulfamethoxazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [6], [7] |
| Bacteria: Synergistetes |
| Synergistetes bacterium (synergistetes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Sulfamethoxazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1511
Drug Info
|
| Interaction Mechanism |
Human Prostaglandin G/H synthase 1 (COX-1) and Synergistetes bacterium co-metabolize the drug Sulfamethoxazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [8], [9] |
|
|
|
|
|
|